X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3360) 3360
Book Review (1184) 1184
Publication (156) 156
Book Chapter (72) 72
Conference Proceeding (8) 8
Dissertation (3) 3
Journal / eJournal (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2533) 2533
humans (2099) 2099
antiplatelet therapy (1219) 1219
clopidogrel (977) 977
aspirin (961) 961
male (888) 888
platelet aggregation inhibitors - therapeutic use (885) 885
cardiac & cardiovascular systems (723) 723
female (710) 710
pharmacology & pharmacy (709) 709
ticlopidine - analogs & derivatives (654) 654
antiplatelet (592) 592
animals (546) 546
platelet aggregation inhibitors - pharmacology (539) 539
percutaneous coronary intervention (536) 536
aged (535) 535
middle aged (533) 533
thrombosis (504) 504
peripheral vascular disease (493) 493
acute coronary syndromes (482) 482
platelet aggregation - drug effects (468) 468
hematology (449) 449
platelet aggregation inhibitors - adverse effects (424) 424
treatment outcome (419) 419
risk factors (409) 409
ticlopidine - therapeutic use (408) 408
myocardial-infarction (374) 374
platelet aggregation inhibitors - administration & dosage (371) 371
anticoagulants (366) 366
cardiology (363) 363
blood platelets - drug effects (357) 357
antiplatelet agents (343) 343
aspirin - therapeutic use (328) 328
medicine & public health (328) 328
drug therapy (321) 321
coronary heart disease (315) 315
prasugrel (311) 311
stroke (310) 310
blood platelets (309) 309
drug therapy, combination (295) 295
ticagrelor (295) 295
abridged index medicus (292) 292
prevention (288) 288
acute coronary syndrome (284) 284
care and treatment (280) 280
dual antiplatelet therapy (280) 280
acute myocardial-infarction (271) 271
platelets (268) 268
aggregation (263) 263
risk (251) 251
analysis (249) 249
double-blind (239) 239
cardiovascular (236) 236
cardiovascular disease (236) 236
heart attacks (233) 233
cardiac patients (232) 232
platelet aggregation (224) 224
inhibition (223) 223
stents (223) 223
adult (222) 222
hemorrhage - chemically induced (222) 222
therapy (222) 222
acute coronary syndrome - drug therapy (216) 216
cardiovascular diseases (214) 214
mortality (212) 212
health aspects (206) 206
ticlopidine - administration & dosage (205) 205
dose-response relationship, drug (204) 204
surgery (201) 201
internal medicine (200) 200
ticlopidine - adverse effects (197) 197
anticoagulants - therapeutic use (193) 193
research (192) 192
medicine, general & internal (189) 189
secondary prevention (189) 189
thrombosis - prevention & control (183) 183
antiplatelet drugs (182) 182
myocardial infarction (182) 182
time factors (179) 179
bleeding (178) 178
blood platelets - metabolism (178) 178
chemistry, medicinal (173) 173
dosage and administration (172) 172
antiplatelet activity (170) 170
low-dose aspirin (169) 169
intervention (168) 168
elevation myocardial-infarction (166) 166
thrombin (166) 166
aspirin - administration & dosage (165) 165
rats (163) 163
artery-disease (159) 159
ticlopidine - pharmacology (159) 159
fibrinolytic agents - therapeutic use (158) 158
activation (156) 156
patients (155) 155
drug interactions (154) 154
platelet inhibition (154) 154
aged, 80 and over (153) 153
st-segment elevation (152) 152
clinical trials (150) 150
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3324) 3324
French (45) 45
German (20) 20
Japanese (15) 15
Spanish (15) 15
Russian (6) 6
Polish (4) 4
Chinese (2) 2
Korean (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cardiovascular Translational Research, ISSN 1937-5387, 2/2014, Volume 7, Issue 1, pp. 91 - 100
In acute coronary syndromes (ACS), a dual antiplatelet regimen with an adenosine diphosphate (ADP) receptor antagonist plus aspirin has become the cornerstone... 
Human Genetics | Biomedical Engineering | Prasugrel | Medicine & Public Health | PCI | Cardiology | Ticagrelor | Acute coronary syndrome | Medicine/Public Health, general | Biomedicine general | MEDICINE, RESEARCH & EXPERIMENTAL | CARDIAC & CARDIOVASCULAR SYSTEMS | GUIDELINES | ANTIPLATELET | INHIBITS ADENOSINE UPTAKE | CLOPIDOGREL | THERAPY | PLATELET INHIBITION | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | Piperazines - administration & dosage | Prasugrel Hydrochloride | Myocardial Infarction - mortality | Thiophenes - adverse effects | Humans | Clinical Protocols | Acute Coronary Syndrome - mortality | Thiophenes - administration & dosage | Fibrinolytic Agents - adverse effects | Percutaneous Coronary Intervention - instrumentation | Time Factors | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Stroke - mortality | Myocardial Infarction - etiology | Stents | Platelet Aggregation Inhibitors - adverse effects | Coronary Thrombosis - mortality | Drug Administration Schedule | Time-to-Treatment | Treatment Outcome | Adenosine - administration & dosage | Piperazines - adverse effects | Acute Coronary Syndrome - blood | Stroke - etiology | Adenosine - analogs & derivatives | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Coronary Thrombosis - etiology | Fibrinolytic Agents - administration & dosage | Percutaneous Coronary Intervention - adverse effects | Research Design | Germany | Medical colleges | Aspirin | Care and treatment | Cardiac patients | Clinical trials | Comparative analysis | Coronary heart disease | Stent (Surgery) | Adenosine triphosphatase | Index Medicus
Journal Article
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 2014, Volume 63, Issue 3, pp. 182 - 192
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2016, Volume 116, Issue 7, pp. 96 - 102
Summary Delays in the onset of action of prasugrel during primary percutaneous coronary intervention (PPCI) have been reported and could be related to the... 
Cellular Haemostasis and Platelets | Prasugrel | inhibitors | Morphine | Platelet reactivity | Antiplatelet medications | P2Y | antiplatelet medications | TICAGRELOR | platelet reactivity | TRITON-TIMI 38 | morphine | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | P2Y inhibitors | PLATELET INHIBITION | IMPROVEMENT | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEMATOLOGY | ASSOCIATION
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0186013 - e0186013
Background Data from available studies suggest that the presence of ST-elevation myocardial infarction (STEMI) may be associated with delayed and attenuated... 
PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | PHARMACOKINETICS | MORPHINE | THROMBOSIS | MULTIDISCIPLINARY SCIENCES | PLATELET INHIBITION | PHARMACODYNAMICS | PRASUGREL | RANDOMIZED CONTROLLED-TRIAL | STEMI PATIENTS | Purinergic P2Y Receptor Antagonists - pharmacology | Adenosine - pharmacokinetics | Prospective Studies | Non-ST Elevated Myocardial Infarction - blood | Humans | Middle Aged | Purinergic P2Y Receptor Antagonists - pharmacokinetics | ST Elevation Myocardial Infarction - drug therapy | Biological Availability | Male | Adenosine - pharmacology | ST Elevation Myocardial Infarction - blood | Platelet Aggregation Inhibitors - blood | Adenosine - blood | Adenosine - analogs & derivatives | Female | Aged | Non-ST Elevated Myocardial Infarction - drug therapy | Platelet Aggregation Inhibitors - pharmacokinetics | Blood Platelets - drug effects | Complications and side effects | Care and treatment | Usage | Analysis | Patient outcomes | Liquid chromatography | Dosage and administration | Bioavailability | Ticagrelor | Mass spectrometry | Heart attack | Myocardial infarction | Heart attacks | Internal medicine | Cardiovascular disease | Mass spectroscopy | Pharmacology | Patients | Thrombosis | Medicine | Elevation | Blood platelets | Coronary vessels | Electrocardiography | Infarction | Clinical medicine | Cardiology | Drug dosages | Pharmaceutical sciences | Plasmas (physics) | Index Medicus
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 08/2017, Volume 6, Issue 8, p. n/a
Background-Patients receiving oral anticoagulation in addition to dual-antiplatelet therapy are known to be at high risk for bleeding events; thus, the... 
stent | atrial fibrillation | myocardial infarction | Myocardial infarction | Stent | Atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | METAANALYSIS | THROMBOSIS | BARE-METAL STENTS | PERCUTANEOUS CORONARY | EUROPEAN-SOCIETY | DUAL ANTIPLATELET THERAPY | TASK-FORCE | ANTITHROMBOTIC THERAPY | DRUG-ELUTING STENTS | Multivariate Analysis | Drug-Eluting Stents - trends | Anticoagulants - administration & dosage | United States | Humans | Middle Aged | Male | Atrial Fibrillation - physiopathology | Prosthesis Design | Myocardial Infarction - therapy | Percutaneous Coronary Intervention - instrumentation | Time Factors | Guideline Adherence - trends | Hospitals - trends | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Female | Myocardial Infarction - physiopathology | Registries | Retrospective Studies | Atrial Fibrillation - diagnosis | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Percutaneous Coronary Intervention - trends | Stroke - prevention & control | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Anticoagulants - adverse effects | Chi-Square Distribution | Myocardial Infarction - complications | Stroke - etiology | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Practice Guidelines as Topic | Index Medicus
Journal Article
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, ISSN 0014-2972, 06/2018, Volume 48, pp. 157 - 157
Conference Proceeding
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0171486 - e0171486
Journal Article
Future Medicinal Chemistry, ISSN 1756-8919, 2018, Volume 10, Issue 16, pp. 1957 - 1970
Aim: The modification of platelet inhibitor to enhance its targeting capacity toward platelets is of clinical importance. Thus, (1R, 3S)-1-methyl-1, 2, 3,... 
docking | targeting | anti-aggregation | P-selectin | GPIIb/IIIa | ISCHEMIC-STROKE PATIENTS | DESIGN | CHEMISTRY, MEDICINAL | REACTIVITY | ANTIPLATELET AGGREGATION ACTIVITY | DELIVERY-SYSTEM | THERAPY | CLOPIDOGREL | AGENTS | INHIBITOR | EXPRESSION
Journal Article
European Journal of Cardio-Thoracic Surgery, ISSN 1010-7940, 4/2008, Volume 33, Issue 4, pp. 531 - 536
Journal Article